Literature DB >> 1663453

Preferential block of the veratridine-induced, non-inactivating Na+ current by R56865 in single cardiac Purkinje cells.

F Verdonck1, F V Bielen, L Ver Donck.   

Abstract

The effect of the cardioprotective agent R56865 on the veratridine (VTD)-modified sodium current was investigated in single rabbit cardiac Purkinje cells and ventricular myocytes. A steady, tetrodotoxin (TTX)-sensitive Na+ current (the non-inactivating Na+ current) was absent in most cells studied. In the presence of veratridine (15 x 10(-6) M) a non-inactivating Na+ current could be elicited at membrane potentials between -80 to +60 mV, with a maximum at about 0 mV. R56865 blocked this current effectively. The concentration for half maximal inhibition of the non-inactivating Na+ current was 2 x 10(-7) M. Blockade of this Na+ current by R56865 increased with depolarization. R56865 was much more effective in inhibiting the non-inactivating Na+ current than in inhibiting time-dependent Na+ currents elicited by short depolarizing pulses. The blocking effect of R56865 on the steady state influx of Na+ may contribute to cardioprotection in depolarized cells and in cells with modified Na+ channels as may occur during ischemia and reperfusion.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1663453     DOI: 10.1016/0014-2999(91)90893-u

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  9 in total

Review 1.  The role of Na+/H+ exchange in ischemia-reperfusion.

Authors:  H M Piper; C Balser; Y V Ladilov; M Schäfer; B Siegmund; M Ruiz-Meana; D Garcia-Dorado
Journal:  Basic Res Cardiol       Date:  1996 May-Jun       Impact factor: 17.165

2.  Hypoxia increases persistent sodium current in rat ventricular myocytes.

Authors:  Y K Ju; D A Saint; P W Gage
Journal:  J Physiol       Date:  1996-12-01       Impact factor: 5.182

3.  The rise of [Na(+)] (i) during ischemia and reperfusion in the rat heart-underlying mechanisms.

Authors:  Iwan A Williams; Xiao-hui Xiao; Yue-kun Ju; David G Allen
Journal:  Pflugers Arch       Date:  2007-03-14       Impact factor: 3.657

4.  R 56865 exerts cardioprotective properties independent of the intracellular Na(+)-overload in the guinea pig heart.

Authors:  Matthias Hartmann; Ulrich K M Decking
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-09-02       Impact factor: 3.000

5.  Effects of R 56865 on postischemic ventricular function in isolated rat working heart preparations obtained from healthy, diabetic and hypertensive animals.

Authors:  A J Pijl; M G Hendriks; K L Kam; M Paffendorf; P A van Zwieten
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-06       Impact factor: 3.000

6.  Effect of R56865 on cardiac sarcoplasmic reticulum function and its role as an antagonist of digoxin at the sarcoplasmic reticulum calcium release channel.

Authors:  S J McGarry; E Scheufler; A J Williams
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

7.  R56865 is antifibrillatory in reperfused ischemic guinea-pig hearts, even when given only during reperfusion.

Authors:  E Scheufler; A Mozes; I Guttmann; B Wilffert
Journal:  Cardiovasc Drugs Ther       Date:  1995-08       Impact factor: 3.727

Review 8.  The role of late I Na in development of cardiac arrhythmias.

Authors:  Charles Antzelevitch; Vladislav Nesterenko; John C Shryock; Sridharan Rajamani; Yejia Song; Luiz Belardinelli
Journal:  Handb Exp Pharmacol       Date:  2014

9.  Veratrine-induced tetanic contracture of the rat isolated left atrium. Evidence for novel direct protective effects of prazosin and WB4101.

Authors:  B Le Grand; A Marty; S Vieu; J M Talmant; G W John
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-08       Impact factor: 3.000

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.